{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T05:44:23Z","timestamp":1748843063535},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,2,27]],"date-time":"2015-02-27T00:00:00Z","timestamp":1424995200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s40618-015-0237-3","type":"journal-article","created":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T04:27:55Z","timestamp":1424924875000},"page":"643-651","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Inadequacy of initiating rosuvastatin then metformin on biochemical profile of polycystic ovarian syndrome patients"],"prefix":"10.1007","volume":"38","author":[{"given":"G.","family":"Ghazeeri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. A.","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Skaff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Harajly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Awwad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,27]]},"reference":[{"issue":"2","key":"237_CR1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.fertnstert.2008.06.006","volume":"92","author":"C Kaya","year":"2009","unstructured":"Kaya C, Cengiz SD, Berker B, Demirtas S, Cesur M, Erdogan G (2009) Comparative effects of atorvastatin and simvastatin on the plasma total homocysteine levels in women with polycystic ovary syndrome: a prospective randomized study. Fertil Steril 92(2):635\u2013642","journal-title":"Fertil Steril"},{"issue":"1","key":"237_CR2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1056\/NEJMct0707092","volume":"358","author":"JE Nestler","year":"2008","unstructured":"Nestler JE (2008) Metformin for the treatment of the polycystic ovary syndrome. N Engl J Med 358(1):47\u201354","journal-title":"N Engl J Med"},{"issue":"1","key":"237_CR3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1552-6909.2009.01086.x","volume":"39","author":"S Benson","year":"2010","unstructured":"Benson S, Hahn S, Tan S, Janssen OE, Schedlowski M, Elsenbruch S (2010) Maladaptive coping with illness in women with polycystic ovary syndrome. J Obstet Gynecol Neonatal Nurs 39(1):37\u201345","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"issue":"2","key":"237_CR4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bpobgyn.2007.07.009","volume":"22","author":"R Homburg","year":"2008","unstructured":"Homburg R (2008) Polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 22(2):261\u2013274","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"5","key":"237_CR5","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.ajog.2005.11.009","volume":"194","author":"B Banaszewska","year":"2006","unstructured":"Banaszewska B, Duleba AJ, Spaczynski RZ, Pawelczyk L (2006) Lipids in polycystic ovary syndrome: role of hyperinsulinemia and effects of metformin. Am J Obstet Gynecol 194(5):1266\u20131272","journal-title":"Am J Obstet Gynecol"},{"issue":"7421","key":"237_CR6","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/bmj.327.7421.951","volume":"327","author":"JM Lord","year":"2003","unstructured":"Lord JM, Flight IH, Norman RJ (2003) Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ 327(7421):951\u2013953","journal-title":"BMJ"},{"key":"237_CR7","unstructured":"Lord JM, Flight IH, Norman RJ (2003) Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, d-chiro-inositol) for polycystic ovary syndrome. Cochrane Database Syst Rev (3):CD003053"},{"issue":"6","key":"237_CR8","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1016\/j.fertnstert.2009.11.045","volume":"94","author":"T Kazerooni","year":"2010","unstructured":"Kazerooni T, Shojaei-Baghini A, Dehbashi S, Asadi N, Ghaffarpasand F, Kazerooni Y (2010) Effects of metformin plus simvastatin on polycystic ovary syndrome: a prospective, randomized, double-blind, placebo-controlled study. Fertil Steril 94(6):2208\u20132213","journal-title":"Fertil Steril"},{"issue":"4","key":"237_CR9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/humupd\/dmr001","volume":"17","author":"PC Groot de","year":"2011","unstructured":"de Groot PC, Dekkers OM, Romijn JA, Dieben SW, Helmerhorst FM (2011) PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Human Reprod Update 17(4):495\u2013500","journal-title":"Human Reprod Update"},{"issue":"4","key":"237_CR10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1530\/EJE-11-0755","volume":"166","author":"T Sathyapalan","year":"2012","unstructured":"Sathyapalan T, Atkin SL (2012) Recent advances in cardiovascular aspects of polycystic ovary syndrome. Eur J Endocrinol 166(4):575\u2013583","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"237_CR11","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1210\/jc.2006-1988","volume":"92","author":"B Banaszewska","year":"2007","unstructured":"Banaszewska B, Pawelczyk L, Spaczynski RZ, Dziura J, Duleba AJ (2007) Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: prospective, randomized, crossover trial. J Clin Endocrinol Metab 92(2):456\u2013461","journal-title":"J Clin Endocrinol Metab"},{"issue":"13","key":"237_CR12","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.2165\/00003495-200868130-00001","volume":"68","author":"PH Kodaman","year":"2008","unstructured":"Kodaman PH, Duleba AJ (2008) HMG-CoA reductase inhibitors: do they have potential in the treatment of polycystic ovary syndrome? Drugs 68(13):1771\u20131785","journal-title":"Drugs"},{"issue":"1","key":"237_CR13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-2007-992933","volume":"26","author":"PH Kodaman","year":"2008","unstructured":"Kodaman PH, Duleba AJ (2008) Statins in the treatment of polycystic ovary syndrome. Semin Reprod Med 26(1):127\u2013138","journal-title":"Semin Reprod Med"},{"issue":"12","key":"237_CR14","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1210\/jc.2009-1674","volume":"94","author":"B Banaszewska","year":"2009","unstructured":"Banaszewska B, Pawelczyk L, Spaczynski RZ, Duleba AJ (2009) Comparison of simvastatin and metformin in treatment of polycystic ovary syndrome: prospective randomized trial. J Clin Endocrinol Metab 94(12):4938\u20134945","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"237_CR15","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3923\/pjbs.2011.658.663","volume":"14","author":"N Navali","year":"2011","unstructured":"Navali N, Pourabolghasem S, Fouladi RF, Nikpour MA (2011) Therapeutic effects of biguanide vs. statin in polycystic ovary syndrome: a randomized clinical trial. Pak J Biol Sci 14(11):658\u2013663","journal-title":"Pak J Biol Sci"},{"issue":"pt 1","key":"237_CR16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1258\/acb.2011.011071","volume":"49","author":"T Sathyapalan","year":"2012","unstructured":"Sathyapalan T, Smith KA, Coady AM, Kilpatrick ES, Atkin SL (2012) Atorvastatin therapy decreases androstenedione and dehydroepiandrosterone sulphate concentrations in patients with polycystic ovary syndrome: randomized controlled study. Ann Clin Biochem 49(pt 1):80\u201385","journal-title":"Ann Clin Biochem"},{"issue":"9716","key":"237_CR17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","volume":"375","author":"N Sattar","year":"2010","unstructured":"Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ et al (2010) Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 375(9716):735\u2013742","journal-title":"Lancet"},{"issue":"suppl 1","key":"237_CR18","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.fertnstert.2006.03.012","volume":"86","author":"E Carmina","year":"2006","unstructured":"Carmina E, Azziz R (2006) Diagnosis, phenotype, and prevalence of polycystic ovary syndrome. Fertil Steril 86(suppl 1):S7\u2013S8","journal-title":"Fertil Steril"},{"issue":"2","key":"237_CR19","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1210\/jc.2009-1985","volume":"95","author":"N Agarwal","year":"2010","unstructured":"Agarwal N, Rice SP, Bolusani H, Luzio SD, Dunseath G, Ludgate M et al (2010) Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial. J Clin Endocrinol Metab 95(2):722\u2013730","journal-title":"J Clin Endocrinol Metab"},{"issue":"suppl 3","key":"237_CR20","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.fertnstert.2004.03.037","volume":"82","author":"D Izquierdo","year":"2004","unstructured":"Izquierdo D, Foyouzi N, Kwintkiewicz J, Duleba AJ (2004) Mevastatin inhibits ovarian theca-interstitial cell proliferation and steroidogenesis. Fertil Steril 82(suppl 3):1193\u20131197","journal-title":"Fertil Steril"},{"issue":"4","key":"237_CR21","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.fertnstert.2005.09.030","volume":"85","author":"AJ Duleba","year":"2006","unstructured":"Duleba AJ, Banaszewska B, Spaczynski RZ, Pawelczyk L (2006) Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial. Fertil Steril 85(4):996\u20131001","journal-title":"Fertil Steril"},{"issue":"11","key":"237_CR22","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1210\/jc.2012-2279","volume":"97","author":"T Sathyapalan","year":"2012","unstructured":"Sathyapalan T, Shepherd J, Coady AM, Kilpatrick ES, Atkin SL (2012) Atorvastatin reduces malondialdehyde concentrations in patients with polycystic ovary syndrome. J Clin Endocrinol Metab 97(11):3951\u20133955","journal-title":"J Clin Endocrinol Metab"},{"key":"237_CR23","doi-asserted-by":"crossref","unstructured":"Raval AD, Hunter T, Stuckey B, Hart RJ (2011) Statins for women with polycystic ovary syndrome not actively trying to conceive. Cochrane Database Syst Rev (10):CD008565","DOI":"10.1002\/14651858.CD008565.pub2"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0237-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-015-0237-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0237-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T23:03:39Z","timestamp":1559516619000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-015-0237-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,27]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["237"],"URL":"https:\/\/doi.org\/10.1007\/s40618-015-0237-3","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,27]]}}}